Adenomatous Polyps Completed Phase 2 Trials for Erlotinib (DB00530)

Also known as: Adenomatous Polyp

IndicationStatusPhase
DBCOND0030950 (Adenomatous Polyps)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00754494Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or AdenomaPrevention